Syndax Pharmaceuticals (SNDX) Current Leases (2019 - 2026)
Syndax Pharmaceuticals' (SNDX) quarterly Current Leases came in at $487000.0 in Q1 2026, up 29.18% year-on-year from $377000.0 in Q1 2025, and up 3.62% quarter-over-quarter from $470000.0 in Q4 2025.
Syndax Pharmaceuticals (SNDX) Current Leases (2019 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $487000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 29.18% year-over-year to $487000.0 in Q1 2026; TTM through Mar 2026 was $487000.0, a 29.18% increase from a year earlier, with the FY2025 full-year figure at $470000.0, changed 0.21% from the prior year.
- Current Leases grew to $487000.0 in Q1 2026 per SNDX's latest filing, from $470000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.0 million in Q1 2024 and bottomed at $299000.0 in Q2 2022.
- The 5-year median for Current Leases is $471000.0 (2022), against an average of $607000.0.
- Across the five-year window, Current Leases soared 220.07% in 2023 and tumbled 64.93% in 2025, its largest moves.
- Year by year, Current Leases stood at $434000.0 in 2022, then surged by 138.48% to $1.0 million in 2023, then plunged by 54.49% to $471000.0 in 2024, then fell by 0.21% to $470000.0 in 2025, then gained by 3.62% to $487000.0 in 2026.
- Per Business Quant, the three latest SNDX Current Leases figures stand at $487000.0 (Q1 2026), $470000.0 (Q4 2025), and $329000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | 487,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,000.00 |
| Dec 31, 2025 | 470,000.00 |
| Sep 30, 2025 | 329,000.00 |
| Jun 30, 2025 | 344,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Dec 31, 2024 | 471,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 981,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 995,000.00 |
| Jun 30, 2023 | 957,000.00 |
| Mar 31, 2023 | 454,000.00 |
| Dec 31, 2022 | 434,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 331,000.00 |
| Dec 31, 2021 | 361,000.00 |
| Sep 30, 2021 | 369,000.00 |
| Jun 30, 2021 | 397,000.00 |